State Street’s Alzamend Neuro ALZN Stock Holding History

State Street’s Portfolio ALZN Stock Details ALZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24	Closed	-$7.56K	–	4439
2023 Q3	$7.56K	Hold	24	–	–	﹤0.01%	4523
2023 Q2	$16.3K	Hold	24	–	–	﹤0.01%	4615
2023 Q1	$13.6K	Hold	24	–	–	﹤0.01%	4725
2022 Q4	$18K	Buy	+24	New	+$34.7K	﹤0.01%	4750

Other funds holding ALZN

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

State Street's ALZN Position: Q4 2023 in Review

State Street sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 24 shares — an estimated $7.56K sold.

State Street first reported a position in ALZN in Q4 2022 and held it in 4 quarters. The position peaked at $18K in Q4 2022. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

State Street reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
State Street sold 24 Alzamend Neuro shares in Q4 2023, an estimated $7.56K.
State Street first reported a position in Alzamend Neuro in Q4 2022 and held it in 4 quarters.
State Street's Alzamend Neuro position peaked at $18K in Q4 2022.
14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.